You are now leaving the LillyMedical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.
Baricitinib: JAHO/JAIR - BRAVE Trial Program
BRAVE-AA1 is a Phase 2b/3 Clinical Trial in Adults with Severe Alopecia Areata (> 50% Scalp Loss).
Please access the following to view the full trial information: ClinicalTrials.gov (BRAVE-AA1)
Please access the following to view the full trial information: ClinicalTrials.gov (BRAVE-AA1)
- Individual results may vary.
- Patient hairstyles, individual characteristics, image angles, lighting and other variables may influence the appearance of SALT scores.
For questions or to report an Adverse Event or Product complaint, please contact 1-800-LILLYRX (1-800-545-5979).